Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SRPT
#1899
Sarepta Therapeutics, Inc. - Common Stock
21.2
4
USD
-0.02%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.62%
Monthly Change
+37.65%
6 month change
+31.03%
Year Change
+16.07%
Previous Close
21.5
9
Open
21.0
4
Low
21.0
4
High
21.3
2
Volume
568
Markets
US Stock Market
Healthcare
Biotechnology
SRPT
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
1999
Annual report, Q4 FY1999
2000.02.29
Sarepta Therapeutics, Inc. annual report, Q4 FY1999
10-K
1
2
3
4
5
6
7
8
9
News
KROS $20M Takeda Milestone Adds Cash but Revenue Visibility Stays Weak
Should You Buy KROS Stock as Pipeline Promise Meets Revenue Risk?
Sarepta's Q2 Earnings & Sales Beat Estimates, '26 Outlook Updated
Sarepta Therapeutics (SRPT) Q2 Earnings and Revenues Surpass Estimates
Compared to Estimates, Sarepta Therapeutics (SRPT) Q2 Earnings: A Look at Key Metrics
ANI Pharmaceuticals (ANIP) Reports Next Week: Wall Street Expects Earnings Growth
ANI Pharmaceuticals (ANIP) Reports Next Week: Wall Street Expects Earnings Growth
Earnings Preview: Sarepta Therapeutics (SRPT) Q2 Earnings Expected to Decline
SRPT Stock Slides 10% in a Week: Is Dyne Therapeutics a Threat?
Dyne Therapeutics Trades Sideways Over An FDA Hurdle. Is It Time To Take Profits?
uniQure Trends to Watch as Gene Therapy Bets Shift Beyond Hemgenix
SRPT or PRTA: Which Is the Better Value Stock Right Now?